Tang Alex, Almetwali Omar, Zak Stephen G, Bernstein Jenna A, Schwarzkopf Ran, Aggarwal Vinay K
Department of Orthopedic Surgery, NYU Langone Health, New York, USA.
J Clin Orthop Trauma. 2021 Jan 23;16:49-57. doi: 10.1016/j.jcot.2020.12.016. eCollection 2021 May.
Intra-articular corticosteroid (CSI) or hyaluronic acid (HAI) injections alleviate symptoms of osteoarthritis in patients who may be candidates for total hip or total knee arthroplasty (THA/TKA). However, their effect on time to total joint arthroplasty (TJA) and complications remains uncertain. We sought to evaluate (1) delay in time to surgery for patients receiving injections prior to THA/TKA (2) incidence of patients that receive injections, (3) type and number of injections, and (4) compare complication rates between patients with and without injections.
We retrospectively reviewed 3340 consecutive TJA (1770 THA and 1570 TKA). Patients were divided into two cohorts depending if they received preoperative intra-articular injection or not. We identified dates of first clinic presentation and index surgery, injection type, total administered, and 90-day complications, including periprosthetic joint infection.
150/1770 THA and 192/1570 TKA patients received injections (8.5%vs.12.2%,p = 0.0004). Time from first presentation to clinic to TJA was significantly greater in patients receiving injections [12.4 ± 11 months vs.7.3 ± 10.7,p < 0.001 for THA; 20.0 ± 17.4 months vs.11.6 ± 15.4,p < 0.001 for TKA]. This delay in time was greater in TKA versus THA (8.4 months vs.5.1,p < 0.001). TKA patients had a higher incidence of receiving HAI versus THA patients (9%vs.0.6%,p < 0.0001). There were no differences in overall complication profiles (p = 0.19 for THA, p = 0.3 for TKA).
Injections are associated with an increased time to TJA by a statistically significant amount, however its clinical significance is debatable. Injections are safe if administered at least three months preoperatively. If patients present with appropriate surgical indications and are ready, we do not recommend intra-articular injections to delay surgery.
关节内注射皮质类固醇(CSI)或透明质酸(HAI)可缓解可能适合全髋关节或全膝关节置换术(THA/TKA)患者的骨关节炎症状。然而,它们对全关节置换术(TJA)时间和并发症的影响仍不确定。我们旨在评估(1)在THA/TKA之前接受注射的患者手术时间的延迟情况,(2)接受注射患者的发生率,(3)注射的类型和次数,以及(4)比较注射组和未注射组患者的并发症发生率。
我们回顾性分析了3340例连续的TJA病例(1770例THA和1570例TKA)。根据患者是否接受术前关节内注射将其分为两个队列。我们确定了首次就诊日期和初次手术日期、注射类型、注射总量以及90天内的并发症,包括假体周围关节感染。
1770例THA患者中有150例、1570例TKA患者中有192例接受了注射(8.5%对12.2%,p = 0.0004)。接受注射的患者从首次就诊到TJA的时间明显更长[THA:12.4±11个月对7.3±10.7个月,p < 0.001;TKA:20.0±17.4个月对11.6±15.4个月,p < 0.001]。TKA患者的时间延迟比THA患者更大(8.4个月对5.1个月,p < 0.001)。TKA患者接受HAI注射的发生率高于THA患者(9%对0.6%,p < 0.0001)。总体并发症情况无差异(THA:p = 0.19;TKA:p = 0.3)。
注射与TJA时间显著延长相关,但其临床意义存在争议。如果在术前至少三个月进行注射是安全的。如果患者有合适的手术指征且已准备好,我们不建议通过关节内注射来延迟手术。